Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 6(3): e17360, 2011 Mar 04.
Article in English | MEDLINE | ID: mdl-21394197

ABSTRACT

OBJECTIVE: Pro-inflammatory cytokines like Interleukin-1 beta (IL-1ß) have been implicated in the pathophysiology of migraine and inflammatory pain. The trigeminal ganglion and calcitonin gene-related peptide (CGRP) are crucial components in the pathophysiology of primary headaches. 5-HT1B/D receptor agonists, which reduce CGRP release, and cyclooxygenase (COX) inhibitors can abort trigeminally mediated pain. However, the cellular source of COX and the interplay between COX and CGRP within the trigeminal ganglion have not been clearly identified. METHODS AND RESULTS: 1. We used primary cultured rat trigeminal ganglia cells to assess whether IL-1ß can induce the expression of COX-2 and which cells express COX-2. Stimulation with IL-1ß caused a dose and time dependent induction of COX-2 but not COX-1 mRNA. Immunohistochemistry revealed expression of COX-2 protein in neuronal and glial cells. 2. Functional significance was demonstrated by prostaglandin E2 (PGE(2)) release 4 hours after stimulation with IL-1ß, which could be aborted by a selective COX-2 (parecoxib) and a non-selective COX-inhibitor (indomethacin). 3. Induction of CGRP release, indicating functional neuronal activation, was seen 1 hour after PGE(2) and 24 hours after IL-1ß stimulation. Immunohistochemistry showed trigeminal neurons as the source of CGRP. IL-1ß induced CGRP release was blocked by parecoxib and indomethacin, but the 5-HT1B/D receptor agonist sumatriptan had no effect. CONCLUSION: We identified a COX-2 dependent pathway of cytokine induced CGRP release in trigeminal ganglia neurons that is not affected by 5-HT1B/D receptor activation. Activation of neuronal and glial cells in the trigeminal ganglion by IL-ß leads to an elevated expression of COX-2 in these cells. Newly synthesized PGE(2) (by COX-2) in turn activates trigeminal neurons to release CGRP. These findings support a glia-neuron interaction in the trigeminal ganglion and demonstrate a sequential link between COX-2 and CGRP. The results could help to explain the mechanism of action of COX-2 inhibitors in migraine.


Subject(s)
Calcitonin Gene-Related Peptide/metabolism , Cyclooxygenase 2/metabolism , Dinoprostone/biosynthesis , Interleukin-1beta/pharmacology , Trigeminal Ganglion/cytology , Trigeminal Ganglion/metabolism , Animals , Cells, Cultured , Cyclooxygenase 2/genetics , Female , Gene Expression Regulation, Enzymologic/drug effects , Male , Models, Biological , Neuroglia/cytology , Neuroglia/drug effects , Neuroglia/enzymology , Neurons/cytology , Neurons/drug effects , Neurons/enzymology , Protein Biosynthesis/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Trigeminal Ganglion/drug effects
2.
Brain Res Brain Res Protoc ; 12(2): 77-82, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14613808

ABSTRACT

We describe a nonradioactive, fluorescence-based method to assess plasma protein extravasation (PPE) in rat dura mater using confocal laser scanning microscopy (CLSM). Unilateral PPE can be induced by electrical stimulation of the ipsilateral trigeminal ganglion (TG) and is widely used as an experimental migraine model. The gold standard to determine PPE in the meninges is based on the detection of radiolabeled albumin ([125]I-BSA). The aim of this study was to develop a nonradioactive, histological method to quantify PPE in the meninges. The fluorescent dye Evans Blue (50 mg/kg) was injected intravenously to the rat 7 min prior to TG stimulation. PPE in dura mater was detected by a CLSM. The amount of extravasated Evans Blue in the dura mater was measured at six to eight regions of interest (ROIs) in the vicinity of large meningeal vessels. The ratio of the average fluorescence intensity within dura mater of the "stimulus side", compared to the contralateral "control side", was calculated for each animal. By using this method, The PPE ratio was 1.67+/-0.12 (n=5). Intravenous injection of three different dosages of the 5HT(1B/1D)-receptor agonist sumatriptan (25, 50, and 100 microg/kg) 15 min prior to stimulation attenuated PPE by 42+/-12%, 49+/-9%, and 86+/-15%, respectively (p<0.01). The approximated ED(50) value was 48 microg/kg. Our results are in accordance with previous reports in the literature using the radioactive approach. We conclude that CLSM is a safe, sensitive, and reliable method to assess PPE in rat meninges in an experimental migaine model.


Subject(s)
Biological Assay/methods , Blood Proteins/analysis , Dura Mater/metabolism , Extravasation of Diagnostic and Therapeutic Materials/diagnosis , Fluorescent Dyes , Microscopy, Confocal/methods , Animals , Biological Assay/instrumentation , Blood Proteins/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Dura Mater/blood supply , Evans Blue/metabolism , Extravasation of Diagnostic and Therapeutic Materials/metabolism , Male , Microscopy, Confocal/instrumentation , Migraine Disorders/metabolism , Migraine Disorders/physiopathology , Neurons, Afferent/metabolism , Rats , Rats, Sprague-Dawley , Reproducibility of Results , Sumatriptan/pharmacology , Trigeminal Ganglion/metabolism , Trigeminal Ganglion/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...